C0269
Cyfra(Ca)21 1
Test Details: CYFRA 21-1 (cytokeratin 19 fragment) has been demonstrated as clinically useful in the prognostication and monitoring of non-small cell lung cancer (NSCLC). Elevated pretreatment levels may be associated with unfavorable prognosis, and decreasing levels during therapy predict an objective response to treatment.
Category
Advanced Routine Diagnostics
Pre-test Information
No special preparation.
Report Delivery
2 working days
Gender
All
Organ
Lung
Cyfra(Ca)21 1
3300
Most Searched Diagnostic Tests